Literature DB >> 25036701

A brain network response to sham surgery.

Mariya V Cherkasova, A Jon Stoessl.   

Abstract

Evaluation of potential therapies for neurological disease has been challenging due to beneficial responses in patients receiving the sham/placebo treatment. Placebo effects are especially prominent in Parkinson's disease (PD), which has become a useful model for studying the neurobiology of placebo responses. In this issue of the JCI, Ko and colleagues identify a neural circuit associated with the placebo response in a PD patient cohort. The observed placebo effect-associated pattern involved metabolic activity increases that corresponded with long-term motor improvements after sham surgery. Presurgery activity in this network was inversely related to sham response, suggesting that this network has potential for identifying sham responders and thus reducing placebo-related variance in surgical trials.

Entities:  

Mesh:

Year:  2014        PMID: 25036701      PMCID: PMC4109557          DOI: 10.1172/JCI77193

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Authors:  Yilong Ma; Chengke Tang; Phoebe G Spetsieris; Vijay Dhawan; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-28       Impact factor: 6.200

2.  Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning.

Authors:  Suzanne N Haber; Ki-Sok Kim; Philippe Mailly; Roberta Calzavara
Journal:  J Neurosci       Date:  2006-08-09       Impact factor: 6.167

3.  Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.

Authors:  Antonio P Strafella; Ji Hyun Ko; Oury Monchi
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

4.  Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies.

Authors:  Catherine J Stoodley; Jeremy D Schmahmann
Journal:  Neuroimage       Date:  2008-09-16       Impact factor: 6.556

5.  A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.

Authors:  Tomas Furmark; Lieuwe Appel; Susanne Henningsson; Fredrik Ahs; Vanda Faria; Clas Linnman; Anna Pissiota; Orjan Frans; Massimo Bani; Paolo Bettica; Emilio Merlo Pich; Eva Jacobsson; Kurt Wahlstedt; Lars Oreland; Bengt Långström; Elias Eriksson; Mats Fredrikson
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

Review 6.  Do "placebo responders" exist?

Authors:  Ted J Kaptchuk; John M Kelley; Aaron Deykin; Peter M Wayne; Louis C Lasagna; Ingrid O Epstein; Irving Kirsch; Michael E Wechsler
Journal:  Contemp Clin Trials       Date:  2008-02-23       Impact factor: 2.226

7.  Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.

Authors:  Christopher G Goetz; Joanne Wuu; Michael P McDermott; Charles H Adler; Stanley Fahn; Curt R Freed; Robert A Hauser; Warren C Olanow; Ira Shoulson; P K Tandon; Sue Leurgans
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

8.  Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

Authors:  Michael G Kaplitt; Andrew Feigin; Chengke Tang; Helen L Fitzsimons; Paul Mattis; Patricia A Lawlor; Ross J Bland; Deborah Young; Kristin Strybing; David Eidelberg; Matthew J During
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

9.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Authors:  Andrew Feigin; Michael G Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

10.  Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response.

Authors:  Fabrizio Benedetti; Michele Lanotte; Luana Colloca; Alessandro Ducati; Maurizio Zibetti; Leonardo Lopiano
Journal:  J Physiol       Date:  2009-06-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.